A Descriptive Study of Medicine Utilisation in Côte D’ivoire
,
Abstract
Background: The measurement of medicine utilisation is of considerable benefit for policymakers in the planning and assessment of medicine policies. This study aimed to describe the temporal trends and utilisation patterns of medicines in Côte d’Ivoire. Methods: We conducted a retrospective description of medicine utilisation at the MUGEFCI. Main subscribers and beneficiaries aged 15 and over who used at least one drug reimbursed between 1st January 2014 and 31st December 2018 were included. Data were retrieved from the MUGEFCI database and described via the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) methodology. The results were expressed as defined daily doses per 1,000 insureds per day (DID). The prevalence and incidence of medicine utilisation were calculated. Results: Between 2014 and 2018, the overall prevalence of use increased from 17.98% (95% CI: 17.90% - 18.05%) to 20.87% (95% CI: 20.80% - 20.94%). There was an 18.96% decrease in the incidence of use, from 6.11% (95% CI: 6.06% - 6.15%) to 4.90% (95% CI: 4.91% - 4.99%). Total medicine utilisation increased from 169.60 DID in 2014 to 218.61 DID in 2018. Each year, the medicines with the highest rate of utilisation were those for the cardiovascular system (C), anti-infectives for systemic use (J) and alimentary tract and metabolism (A). Approximately 50% of the medicine used belong to four therapeutic groups: antibacterials for systemic use (J01), agents acting on the renin-angiotensin system (C09), calcium channel blockers (C08), and drugs used in diabetes (A10). Conclusion: Medicine utilisation has shown an increasing trend. A study of the factors that explain this growth can provide decision-makers with arguments for ensuring that they are used rationally.French Public Health Code (2022) . French Republic. Ministry of Health and Access to Care. Available at : https://sante.gouv.fr/soins-et-maladies/medicaments/le-bon-usage-des-medicaments/article/qu-est-ce-qu-un-medicament. (Accessed: 24 November 2024).
World Health Organisation. (2002). Promoting rational use of medicines : core components. World Health Organisation. Available at : https://iris.who.int/handle/10665/67438. (Accessed: 24 November 2024).
OECD (2021), Health at a Glance 2021: OECD Indicators, Éditions OCDE, Paris, https://doi.org/10.1787/ae3016b9-en (Accessed: 23 November 2024).
Gu Q, Dillon CF, Burt VL (2010). Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. NCHS Data Brief. 2010 Sep;(42):1-8. PMID: 20854747.
Mousnad, M. A., Shafie, A. A., & Ibrahim, M. I. (2014). Systematic review of factors affecting pharmaceutical expenditures. Health Policy (Amsterdam, Netherlands), 116(2‑3), 137‑146. https://doi.org/10.1016/j.healthpol.2014.03.010
Alkan, Ö., & Elmali, K. (2015). The Determination of the Factors Affecting Pharmaceutical Consumption in Respect to Provinces in Turkey. Mediterranean Journal of Social Sciences. https://doi.org/10.5901/mjss.2015.v6n6p356
Galès, C. L. (2018). Évolution, déterminants et régulation des dépenses de médicaments en France. médecine/sciences, 34(1). https:/doi.org/10.1051/medsci/20183401018
Marković-Peković V, Ljubica Bojanić Lj, Stoisavljević-Šatara S.(2019). The characteristics of the outpatient utilisation of medicines in the Republic of Srpska from 2009-2017. Scr Med ;50(4):167-76
Vincent K.C. Yan, Joseph E. Blais, Xue Li, Celine S.L. Chui, Li Wei, Bryan P. Yan, Martin R.J. Knapp, Chung Wah Siu, Ian C.K. Wong, Esther W. Chan. (2021). Trends in Cardiovascular Medicine Use in 65 Middle- and High-Income Countries, JAAmerican College of Cardiology, 77, 7,1021-1023. https://doi.org/10.1016/j.jacc.2020.12.025
Bouwer, J. C., Govender, S., & Robertson, L. J. (2021). Medicines used in mental, neurological and substance use disorders in Gauteng, South Africa : A secondary analysis of the 2017–2018 provincial pharmaceutical database, Part 1. South African Journal of Psychiatry, 27. https://www.ajol.info/index.php/sajpsyc/article/view/241160
Auvray, L., & Sermet, C. (2002). Consommations et prescriptions pharmaceutiques chez les personnes âgées :Un état des lieux. Gérontologie et société, 25103(4), 13‑27. https://doi.org/10.3917/gs.103.0013
Shah, R. B., Gajjar, B. M., & Desai, S. V. (2012). Drug utilisation pattern among geriatric patients assessed with the anatomical therapeutic chemical classification/defined daily dose system in a rural tertiary care teaching hospital. International Journal of Nutrition, Pharmacology, Neurological Diseases, 2(3), 258. https://doi.org/10.4103/2231-0738.99480
Gama, H., Torre, C., Guerreiro, J. P., Azevedo, A., Costa, S., & Lunet, N. (2017). Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal. BMC Health Services Research, 17(1), 449. https://doi.org/10.1186/s12913-017-2401-2
Lisauskienė, I., Garuolienė, K., & Gulbinovič, J. (2017). Utilisation of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003–2012. Medicina, 53(4), Article 4. https://doi.org/10.1016/j.medici.2017.07.004
Kalinić, D., Škrbić, R., Vulić, D., Stojaković, N., Stoisavljević-Šatara, S., Stojiljković, M. P., Marković-Peković, V., Golić Jelić, A., Pilipović-Broćeta, N., Wong, N. D., & Godman, B. (2022). Trends in Antihypertensive Medicine Utilisation in the Republic of Srpska, Bosnia and Herzegovina : An Eleven-Year Follow-Up. Frontiers in Pharmacology, 13, 889047. https://doi.org/10.3389/fphar.2022.889047
WHO Regional Office for Africa. (2014). The health of the people: what works - the African Regional Health Report 2014. Available at: http://extranet.who.int/iris/restricted/bitstream/handle/10665/137377/9789290232612.pdf;jsessionid=9B283B2A92CD71D81DF839709FB07A4C?sequence=4 (accessed: 5 October 2024).
African Development Bank.. (2022) Human Development. Available at: https://www.afdb.org/en/knowledge/publications/trackingafrica%E2%80%99s-progress-in-figures/human-development (Accessed: 23 November 2024).
Soussi-Tanani, D., Alaoui, K., Belaiche, A., Hassar, M., & Cherrah, Y. (2008). Analyse de la consommation des antihypertenseurs au Maroc : Période 1991-2005. Therapies, 63(2), 129‑133. https://doi.org/10.2515/therapie:2008035
Mousnad MA, Ibrahim MIM, Palaian S, Shafie AA. (2017). Medicines utilisation and trends in Sudan between 2006 and 2010. Trop J Pharm Res ; 16(7): 1717.
Ain, M. R., Shahzad, N., Aqil, M., Alam, M. S., & Khanam, R. (2010). Drug utilisation pattern of antibacterials used in ear, nose and throat outpatient and inpatient departments of a university hospital at New Delhi, India. Journal of Pharmacy and Bioallied Sciences, 2(1), 8. https://doi.org/10.4103/0975-7406.62695
Ali, H., Zafar, F., Alam, S., Beg, A. E., Bushra, R., Manzoor, A., Naqvi, G. R., Yasmeen, R., Shafiq, Y., Tariq, A., Zubair, S., & Saleem, S. (2018). Drug utilisation and prescribing pattern of antibiotics in a tertiary care setups; trends and practices. Pak. J. Pharm. Sci. 2018 Mar;31(2(Suppl.)):691-697.
Landstedt, K., Sharma, A., Johansson, F., Lundborg, C. S., & Sharma, M. (2017). Antibiotic prescriptions for inpatients having nonbacterial diagnosis at medicine departments of two private sector hospitals in Madhya Pradesh, India : A cross-sectional study. https://doi.org/10.1136/bmjopen-2016-012974
Rasmussen L, Wettermark B, Steinke D, Pottegård A. Core concepts in pharmacoepidemiology: Measures of drug utilisation based on individual-level drug dispensing data. Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1015-1026. doi: 10.1002/pds.5490
Štimac, D., Polić-Vižintin ,Marina, Škes ,Marija, Cattunar ,Albert, Cerović ,Robert, & and Stojanović, D. (2010). Utilisation of cardiovascular drugs in Zagreb 2001-2005. Acta Cardiologica, 65(2), 193‑201. https://doi.org/10.2143/AC.65.2.2047053
Hollingworth, S. A., Ankrah, D., Uzochukwu, B. S. C., Okeke, C. C., Ruiz, F., & Thacher, E. (2022). Antihypertensive medicine use differs between Ghana and Nigeria. BMC Cardiovascular Disorders, 22(1), 368. https://doi.org/10.1186/s12872-022-02799-z
Agence Nationale de la statistique de Côte d’Ivoire (2021) . Récensement général dela population et de l'habitat 2021. Résultats globaux définitifs. Available at: https://www.ins.ci/RGPH2021/RESULTATS%20DEFINITIFSRP21.pdf(Accessed: 25 November 2024).
| Files | ||
| Issue | Vol 11 No 2 (2025) | |
| Section | Original Article(s) | |
| Keywords | ||
| Medicine utilisation, ATC/DDD methodology, Africa, Mutual Insurance Company, Retrospective analysis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
